Clinical
RSSArticles
-
Emerging Options for Malaria Prevention
New data suggest that combining vaccination with chemoprophylaxis is better than either intervention alone, and a small pilot study suggests that a monoclonal antibody infusion is effective in preventing malaria infections.
-
Is There a Difference Between COVID-19 and Non-COVID-19 ARDS?
Comparison of a small COVID-19 acute respiratory distress syndrome (ARDS) cohort with a historical pre-COVID-19 ARDS cohort found some differences in physiologic parameters and biomarkers, but not enough evidence to warrant deviation from known management guidelines.
-
Beyond Benzodiazepines: Adjuncts for the Management of Alcohol Withdrawal in the ICU
Although benzodiazepines are the mainstay of prevention and treatment of alcohol withdrawal syndrome, adjunct medications are used increasingly, with the goal of reducing cumulative benzodiazepine exposure and decreasing both hospital and intensive care unit admission and length of stay.
-
COVID-19 Vaccination, Pregnancy, Lactation, and Fertility: What Should the OB/GYN Know?
With the increasing circulation of the Delta variant, it has become critically important for the OB/GYN to discuss COVID-19 vaccination with patients, and, specifically, to address concerns related to pregnancy, lactation, and fertility. This article reviews the most recent guidance from the American College of Obstetricians and Gynecologists, the Society of Maternal-Fetal Medicine, and the American Society for Reproductive Medicine on vaccination in reproductive-age individuals.
-
Vaginal Misoprostol vs. Prostaglandin E2 Pessary for Induction of Labor at Term
In this randomized, noninferiority, clinical trial of pregnant women who underwent induction of labor with misoprostol compared to dinoprostone, the rate of vaginal delivery within 24 hours was higher in the misoprostol group. Maternal satisfaction, assessed by a visual analog scale, also was higher. Although the noninferiority of dinoprostone to misoprostol could not be demonstrated, the clinical risk-to-benefit ratio justifies the use of both drugs.
-
Highlights from the CDC’s Updated 2021 Sexually Transmitted Infections Treatment Guidelines
The Centers for Disease Control and Prevention updated their sexually transmitted infections treatment guidelines with important considerations for women’s health providers, such as new recommendations for Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis, pelvic inflammatory disease, and Mycoplasma genitalium.
-
Does Music Lower Preoperative Anxiety in Pelvic Reconstructive Surgery Patients?
Listening to music may lower preoperative anxiety in patients undergoing pelvic reconstructive surgery.
-
COVID-19 Vaccine mRNA Injection (Comirnaty)
Comirnaty is the first COVID-19 vaccine to receive full FDA approval.
-
Functional Cognitive Disorder: An Important Condition to Recognize
Functional cognitive disorder (FCD) can describe cognitive difficulties that are present where there is no biologic cause, but a lack of consensus in diagnostic criteria limits its use in clinical practice and research. The authors proposed an operational definition for FCD as the cognitive phenotype of functional neurological disorder.
-
Women Athletes Need Evidence-Based Reproductive Health Treatment, Information
Menstrual cycles can vary and be inconsistent among female athletes. Physicians and other providers could miss important health problems if they downplay athletes’ cycle changes or differences. A new study shows that a tool, called the Health and Reproductive Survey, can assess menstrual function in physically active females.